시장보고서
상품코드
1193256

니코틴대체요법 시장 : 제품별(껌, 로젠지, 패치 등), 판매 채널별(온라인, 오프라인), 장소별(병원 및 탈중독 센터, 자택) - 세계 기회 분석 및 산업 예측(2021-2031년)

Nicotine Replacement Therapy Market By Product (Gums, Lozenges, Patches, Others), By Sales Channel (Online, Offline), By Location (Hospitals and Deaddiction centers, Home): Global Opportunity Analysis and Industry Forecast, 2021-2031

발행일: | 리서치사: Allied Market Research | 페이지 정보: 영문 290 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 니코틴대체요법 시장은 2021년에 26억 5900만 달러, 2031년에는 59억 5595만 달러에 이르렀으며, 2022년부터 2031년까지의 CAGR은 8.3%를 기록할 것으로 예상됩니다.

니코틴대체요법은 담배 이외의 수단으로 니코틴을 섭취하여 담배 사용 장애인을 치료하는 방법으로 의학적으로 승인되었습니다. 니코틴 검이나 패치와 같은 니코틴 대체 제품은 흡연을 멈출 때 경험하는 금단 증상을 줄이기 위해 니코틴을 체내에 공급하고 흡연하고 싶은 충동을 억제하기위한 구강 활동의 대안으로 작용합니다.

도시 지역에서 높은 흡연율로 인해 담배 총이 증가하고 있습니다는 것은 니코틴대체요법 시장의 성장을 이끌고 있습니다. 또, 농촌부에서는 남녀 모두 담배를 씹는 비율이 높고, 이것이 한층 더 암의 리스크를 높이고 있습니다. 예를 들어, 2020년 10월에 발표된 미국암협회(ACS)의 보고서에 따르면, 미국에서는 담배 사용이 여전히 예방 가능한 주요 사인이며, 매년 약 5명에 1명의 사망을 차지하고 있습니다 합니다. 이 자료에서 흡연은 미국에서 전암의 약 20%, 전암사멸의 약 30%를 일으키는 것으로 알려져 있습니다.

또한 암에 대한 의식의 증가와 담배 소비에 따른 위험에 대한 인식을 촉구하는 각국 정부의 대처의 증가가 시장의 성장에 기여하고 있습니다. 또한 다양한 비정부 조직과 비영리 단체가 흡연의 유해한 영향에 대한 인식을 촉진하기 위해 활동하고 있으며, 이는 니코틴대체요법의 수요를 더욱 밀어 올리고 있습니다.

금연을 촉진하는 소셜 미디어의 계발 캠페인과 정부의 계발 프로그램을 통해 니코틴 검과 패치와 같은 금연 보조제에 대한 수요가 증가하고 있습니다는 것은 시장 성장을 위한 충분한 기회를 제공합니다. 니코틴대체요법은 금단 증상을 줄이고 담배를 피우고 싶은 욕망을 억제하는 데 도움이됩니다.

또한, 첨단 니코틴대체요법 개발을 위한 연구개발 활동 증가, 제품 승인, 주요 기업의 새로운 제품인 상시가 시장 성장을 추진하고 있습니다. 니코틴 껌과 로치와 같은 환자 중심 제품 개발은 니코틴 대체 제품의 수요를 뒷받침하고 있습니다. 그러나 정부의 엄격한 규제와 많은 국가에서 전자 담배의 금지는 시장 성장을 방해 할 수 있습니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 개요

  • 시장의 정의와 범위
  • 주요 조사 결과
    • 주요 투자 포켓
  • Porter's Five Forces 분석
  • 시장 역학
    • 촉진 요인
    • 억제 요인
    • 기회
  • COVID-19의 시장에의 영향도 분석

제4장 니코틴 치환 요법 시장 : 제품별

  • 개요
    • 시장 규모 및 예측
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 로젠지
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 패치
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 기타
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별

제5장 니코틴 치환 요법 시장 : 판매 채널별

  • 개요
    • 시장 규모 및 예측
  • 온라인
    • 주요 시장 동향, 성장 요인과 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 오프라인
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별

제6장 니코틴 치환 요법 시장 : 부위별

  • 개요
    • 시장 규모·예측
  • 병원, 탈의존 센터
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
    • 병원·탈의존 센터용 니코틴 치환 요법 시장 : 성별
      • 남성 시장 규모·예측 : 지역별
      • 여성 시장 규모·예측 : 지역별
    • 주요 시장 동향 · 성장 요인 · 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
    • 가정용 니코틴 치환 요법 시장 : 성별
      • 남성 시장 규모·예측 : 지역별
      • 여성 시장 규모·예측 : 지역별

제7장 니코틴 치환 요법 시장 : 지역별

  • 개요
    • 시장 규모·예측
  • 북미
    • 주요 동향과 기회
    • 북미 시장 규모·예측 : 제품별
    • 북미 시장 규모·예측 : 판매 채널별
    • 북미 시장 규모·예측 : 장소별
      • 북미의 병원·탈의존 센터 니코틴 치환 요법 시장 : 성별
      • 북미 가정용 니코틴대체요법 시장 : 성별
    • 북미 시장 규모·예측 : 국가별
      • 미국
      • 캐나다
      • 멕시코
  • 유럽
    • 주요 동향과 기회
    • 유럽 시장 규모·예측 : 제품별
    • 유럽 시장 규모·예측 : 판매 채널별
    • 유럽 시장 규모·예측 : 장소별
      • 유럽의 병원·탈의존 센터용 니코틴 치환 요법 시장 : 성별
      • 유럽 가정용 니코틴대체요법 시장 : 성별
    • 유럽 시장 규모·예측 : 국가별
      • 독일
      • 프랑스
      • 영국
      • 이탈리아
      • 스페인
      • 기타 유럽 지역
  • 아시아태평양
    • 주요 동향과 기회
    • 아시아태평양의 시장 규모·예측 : 제품별
    • 아시아태평양의 시장 규모·예측 : 판매 채널별
    • 아시아태평양의 시장 규모·예측 : 장소별
      • 아시아태평양의 병원·탈의존 센터용 니코틴 치환 요법 시장 : 남녀별
      • 아시아태평양 가정용 니코틴대체요법 시장 : 성별
    • 아시아태평양의 시장 규모·예측 : 국가별
      • 일본
      • 중국
      • 호주
      • 인도
      • 한국
      • 기타 아시아태평양
  • LAMEA
    • 주요 동향과 기회
    • LAMEA의 시장 규모·예측 : 제품별
    • LAMEA의 시장 규모·예측 : 판매채널별
    • LAMEA의 시장 규모·예측 : 입지별
      • LAMEA의 병원과 탈의존 센터의 니코틴 치환 요법 시장 : 성별
      • LAMEA 가정용 니코틴대체요법 시장 : 성별
    • LAMEA의 시장 규모·예측 : 국가별
      • 브라질
      • 사우디아라비아
      • 남아프리카 공화국
      • 기타 LAMEA

제8장 경쟁 상황

  • 소개
  • 주요 성공 전략
  • 주요 10개사의 제품 매핑
  • 경쟁 대시보드
  • 경합의 히트 맵
  • 톱 기업의 포지셔닝, 2021년

제9장 기업 프로필

  • Cipla Ltd
  • Fertin Pharma Limited
  • GlaxoSmithKline plc
  • Johnson & Johnson Inc
  • Lucy Goods Inc
  • Pfizer Inc
  • PL Developments
  • Rubicon Research Pvt Ltd
  • Sparsha Pharma International Pvt. Ltd.
  • Zydus Cadila
ksm 23.03.27

The global nicotine replacement therapy market was valued at $2,659.0 million in 2021, and is projected to reach $5,955.95 million by 2031, registering a CAGR of 8.3% from 2022 to 2031.

Nicotine replacement therapy is a medically approved way to treat people with tobacco use disorder by taking nicotine by means other than tobacco. The nicotine replacement products such as nicotine gum and patches work by providing nicotine to the body to decrease the withdrawal symptoms experienced when smoking is stopped and as a substitute oral activity to reduce the urge to smoke.

The increase in prevalence of tobacco cancer owing to high cigarette smoking rate in urban cities drives the growth of the nicotine replacement therapy market. In addition, there is high tobacco chewing rate in rural area in both males and females, which further increases the risk of cancer. For instance, according to the report of American Cancer Society (ACS) published in October 2020, tobacco use remains the leading preventable cause of death in the U.S., accounting for about 1 in 5 deaths each year. From the same source, smoking causes about 20% of all cancers and about 30% of all cancer deaths in the U.S.

Furthermore, rise in awareness about cancer and increase in initiatives by respective governments to promote awareness about the risk associated with tobacco consumption contributes to the growth of the market. In addition, various non-government and non-profit organizations operate to promote awareness about hazardous effects of smoking, which further boosts the demand for nicotine replacement therapy.

The rise in demand for smoking cessation aids such as nicotine gums and patches owing to social media awareness campaigns and government awareness programs motivating people to quit smoking, provides ample opportunities for the market growth. Nicotine replacement therapy reduces the withdrawal symptoms and helps to control the drive to smoke tobacco.

Moreover, the increase in R&D activities for development of advanced nicotine replacement therapy, product approvals, and novel product launches by key players boost the market growth. The patient centric products development such as nicotine gums and lozenges propels the demand for nicotine replacement products. However, strict government regulations and ban of e cigarettes in many countries may hinder the growth of the market.

The nicotine replacement therapy market is segmented based on product, sales channel, location, and region. By product, the market is classified into gums, lozenges, patches, and others. Depending on sales channel, it is divided into online and offline. As per location, it is categorized into hospitals & deaddiction centers and home. The hospitals & deaddiction centers is further divided into male and female. The home segment is further bifurcated into male and female. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include Cipla Limited, Fertin Pharma Ltd., GlaxoSmithKline plc, Johnson & Johnson Inc., Lucy Goods, Inc., Pfizer Inc., PL Developments, Rubicon Research Pvt. Ltd., Sparsha Pharma International Pvt. Ltd., and Zydus Cadila.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the nicotine replacement therapy market analysis from 2021 to 2031 to identify the prevailing nicotine replacement therapy market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the nicotine replacement therapy market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global nicotine replacement therapy market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Gums
  • Lozenges
  • Patches
  • Others

By Sales Channel

  • Online
  • Offline

By Location

  • Hospitals and Deaddiction centers
    • Gender
    • Male
    • Female
  • Home
    • Gender
    • Male
    • Female

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest Of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest Of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest Of LAMEA
  • Key Market Players
    • Cipla Ltd
    • Fertin Pharma Limited
    • GlaxoSmithKline plc
    • Johnson & Johnson Inc 
    • Lucy Goods Inc
    • Pfizer Inc
    • PL Developments
    • Rubicon Research Pvt Ltd
    • Sparsha Pharma International Pvt. Ltd.
    • Zydus Cadila

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Market dynamics
    • 3.4.1.Drivers
    • 3.4.2.Restraints
    • 3.4.3.Opportunities
  • 3.5.COVID-19 Impact Analysis on the market

CHAPTER 4: NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2. Gums
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market share analysis by country
  • 4.3. Lozenges
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market share analysis by country
  • 4.4. Patches
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market share analysis by country
  • 4.5. Others
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market share analysis by country

CHAPTER 5: NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2. Online
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market share analysis by country
  • 5.3. Offline
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market share analysis by country

CHAPTER 6: NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2. Hospitals and Deaddiction centers
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market share analysis by country
    • 6.2.4 Hospitals and Deaddiction centers Nicotine Replacement Therapy Market by Gender
      • 6.2.4.1 Male Market size and forecast, by region
      • 6.2.4.2 Female Market size and forecast, by region
  • 6.3. Home
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market share analysis by country
    • 6.3.4 Home Nicotine Replacement Therapy Market by Gender
      • 6.3.4.1 Male Market size and forecast, by region
      • 6.3.4.2 Female Market size and forecast, by region

CHAPTER 7: NICOTINE REPLACEMENT THERAPY MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Product
    • 7.2.3 North America Market size and forecast, by Sales Channel
    • 7.2.4 North America Market size and forecast, by Location
      • 7.2.4.1 North America Hospitals and Deaddiction centers Nicotine Replacement Therapy Market by Gender
      • 7.2.4.2 North America Home Nicotine Replacement Therapy Market by Gender
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Key market trends, growth factors and opportunities
      • 7.2.5.1.2 Market size and forecast, by Product
      • 7.2.5.1.3 Market size and forecast, by Sales Channel
      • 7.2.5.1.4 Market size and forecast, by Location
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Key market trends, growth factors and opportunities
      • 7.2.5.2.2 Market size and forecast, by Product
      • 7.2.5.2.3 Market size and forecast, by Sales Channel
      • 7.2.5.2.4 Market size and forecast, by Location
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Key market trends, growth factors and opportunities
      • 7.2.5.3.2 Market size and forecast, by Product
      • 7.2.5.3.3 Market size and forecast, by Sales Channel
      • 7.2.5.3.4 Market size and forecast, by Location
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Product
    • 7.3.3 Europe Market size and forecast, by Sales Channel
    • 7.3.4 Europe Market size and forecast, by Location
      • 7.3.4.1 Europe Hospitals and Deaddiction centers Nicotine Replacement Therapy Market by Gender
      • 7.3.4.2 Europe Home Nicotine Replacement Therapy Market by Gender
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Key market trends, growth factors and opportunities
      • 7.3.5.1.2 Market size and forecast, by Product
      • 7.3.5.1.3 Market size and forecast, by Sales Channel
      • 7.3.5.1.4 Market size and forecast, by Location
      • 7.3.5.2 France
      • 7.3.5.2.1 Key market trends, growth factors and opportunities
      • 7.3.5.2.2 Market size and forecast, by Product
      • 7.3.5.2.3 Market size and forecast, by Sales Channel
      • 7.3.5.2.4 Market size and forecast, by Location
      • 7.3.5.3 UK
      • 7.3.5.3.1 Key market trends, growth factors and opportunities
      • 7.3.5.3.2 Market size and forecast, by Product
      • 7.3.5.3.3 Market size and forecast, by Sales Channel
      • 7.3.5.3.4 Market size and forecast, by Location
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Key market trends, growth factors and opportunities
      • 7.3.5.4.2 Market size and forecast, by Product
      • 7.3.5.4.3 Market size and forecast, by Sales Channel
      • 7.3.5.4.4 Market size and forecast, by Location
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Key market trends, growth factors and opportunities
      • 7.3.5.5.2 Market size and forecast, by Product
      • 7.3.5.5.3 Market size and forecast, by Sales Channel
      • 7.3.5.5.4 Market size and forecast, by Location
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Key market trends, growth factors and opportunities
      • 7.3.5.6.2 Market size and forecast, by Product
      • 7.3.5.6.3 Market size and forecast, by Sales Channel
      • 7.3.5.6.4 Market size and forecast, by Location
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Product
    • 7.4.3 Asia-Pacific Market size and forecast, by Sales Channel
    • 7.4.4 Asia-Pacific Market size and forecast, by Location
      • 7.4.4.1 Asia-Pacific Hospitals and Deaddiction centers Nicotine Replacement Therapy Market by Gender
      • 7.4.4.2 Asia-Pacific Home Nicotine Replacement Therapy Market by Gender
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Key market trends, growth factors and opportunities
      • 7.4.5.1.2 Market size and forecast, by Product
      • 7.4.5.1.3 Market size and forecast, by Sales Channel
      • 7.4.5.1.4 Market size and forecast, by Location
      • 7.4.5.2 China
      • 7.4.5.2.1 Key market trends, growth factors and opportunities
      • 7.4.5.2.2 Market size and forecast, by Product
      • 7.4.5.2.3 Market size and forecast, by Sales Channel
      • 7.4.5.2.4 Market size and forecast, by Location
      • 7.4.5.3 Australia
      • 7.4.5.3.1 Key market trends, growth factors and opportunities
      • 7.4.5.3.2 Market size and forecast, by Product
      • 7.4.5.3.3 Market size and forecast, by Sales Channel
      • 7.4.5.3.4 Market size and forecast, by Location
      • 7.4.5.4 India
      • 7.4.5.4.1 Key market trends, growth factors and opportunities
      • 7.4.5.4.2 Market size and forecast, by Product
      • 7.4.5.4.3 Market size and forecast, by Sales Channel
      • 7.4.5.4.4 Market size and forecast, by Location
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Key market trends, growth factors and opportunities
      • 7.4.5.5.2 Market size and forecast, by Product
      • 7.4.5.5.3 Market size and forecast, by Sales Channel
      • 7.4.5.5.4 Market size and forecast, by Location
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Key market trends, growth factors and opportunities
      • 7.4.5.6.2 Market size and forecast, by Product
      • 7.4.5.6.3 Market size and forecast, by Sales Channel
      • 7.4.5.6.4 Market size and forecast, by Location
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Product
    • 7.5.3 LAMEA Market size and forecast, by Sales Channel
    • 7.5.4 LAMEA Market size and forecast, by Location
      • 7.5.4.1 LAMEA Hospitals and Deaddiction centers Nicotine Replacement Therapy Market by Gender
      • 7.5.4.2 LAMEA Home Nicotine Replacement Therapy Market by Gender
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Key market trends, growth factors and opportunities
      • 7.5.5.1.2 Market size and forecast, by Product
      • 7.5.5.1.3 Market size and forecast, by Sales Channel
      • 7.5.5.1.4 Market size and forecast, by Location
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Key market trends, growth factors and opportunities
      • 7.5.5.2.2 Market size and forecast, by Product
      • 7.5.5.2.3 Market size and forecast, by Sales Channel
      • 7.5.5.2.4 Market size and forecast, by Location
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Key market trends, growth factors and opportunities
      • 7.5.5.3.2 Market size and forecast, by Product
      • 7.5.5.3.3 Market size and forecast, by Sales Channel
      • 7.5.5.3.4 Market size and forecast, by Location
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Key market trends, growth factors and opportunities
      • 7.5.5.4.2 Market size and forecast, by Product
      • 7.5.5.4.3 Market size and forecast, by Sales Channel
      • 7.5.5.4.4 Market size and forecast, by Location

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

  • 9.1 Cipla Ltd
    • 9.1.1 Company overview
    • 9.1.2 Key Executives
    • 9.1.3 Company snapshot
    • 9.1.4 Operating business segments
    • 9.1.5 Product portfolio
    • 9.1.6 Business performance
    • 9.1.7 Key strategic moves and developments
  • 9.2 Fertin Pharma Limited
    • 9.2.1 Company overview
    • 9.2.2 Key Executives
    • 9.2.3 Company snapshot
    • 9.2.4 Operating business segments
    • 9.2.5 Product portfolio
    • 9.2.6 Business performance
    • 9.2.7 Key strategic moves and developments
  • 9.3 GlaxoSmithKline plc
    • 9.3.1 Company overview
    • 9.3.2 Key Executives
    • 9.3.3 Company snapshot
    • 9.3.4 Operating business segments
    • 9.3.5 Product portfolio
    • 9.3.6 Business performance
    • 9.3.7 Key strategic moves and developments
  • 9.4 Johnson & Johnson Inc 
    • 9.4.1 Company overview
    • 9.4.2 Key Executives
    • 9.4.3 Company snapshot
    • 9.4.4 Operating business segments
    • 9.4.5 Product portfolio
    • 9.4.6 Business performance
    • 9.4.7 Key strategic moves and developments
  • 9.5 Lucy Goods Inc
    • 9.5.1 Company overview
    • 9.5.2 Key Executives
    • 9.5.3 Company snapshot
    • 9.5.4 Operating business segments
    • 9.5.5 Product portfolio
    • 9.5.6 Business performance
    • 9.5.7 Key strategic moves and developments
  • 9.6 Pfizer Inc
    • 9.6.1 Company overview
    • 9.6.2 Key Executives
    • 9.6.3 Company snapshot
    • 9.6.4 Operating business segments
    • 9.6.5 Product portfolio
    • 9.6.6 Business performance
    • 9.6.7 Key strategic moves and developments
  • 9.7 PL Developments
    • 9.7.1 Company overview
    • 9.7.2 Key Executives
    • 9.7.3 Company snapshot
    • 9.7.4 Operating business segments
    • 9.7.5 Product portfolio
    • 9.7.6 Business performance
    • 9.7.7 Key strategic moves and developments
  • 9.8 Rubicon Research Pvt Ltd
    • 9.8.1 Company overview
    • 9.8.2 Key Executives
    • 9.8.3 Company snapshot
    • 9.8.4 Operating business segments
    • 9.8.5 Product portfolio
    • 9.8.6 Business performance
    • 9.8.7 Key strategic moves and developments
  • 9.9 Sparsha Pharma International Pvt. Ltd.
    • 9.9.1 Company overview
    • 9.9.2 Key Executives
    • 9.9.3 Company snapshot
    • 9.9.4 Operating business segments
    • 9.9.5 Product portfolio
    • 9.9.6 Business performance
    • 9.9.7 Key strategic moves and developments
  • 9.10 Zydus Cadila
    • 9.10.1 Company overview
    • 9.10.2 Key Executives
    • 9.10.3 Company snapshot
    • 9.10.4 Operating business segments
    • 9.10.5 Product portfolio
    • 9.10.6 Business performance
    • 9.10.7 Key strategic moves and developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제